How We Test


The Alimetrix approach

Informed Disease Insight

State of the art diagnostic tools

  • CLIA #01D2113023


Who We Are

We utilize state of the art molecular-based technologies for all of our diagnostic assays. Moreover, our core team has been together since 2000, designing and commercially producing diagnostic assays. With such a longstanding presence in the diagnostic marketplace as assay development pioneers, unique insights have been gained into the diverse requirements of differing diagnostic challenges. This insight, along with the development of proprietary core skills and innovations has allowed Alimetrix to assemble an assay repertoire that utilizes the most ideal detection methodologies available for each diagnostic task. Our proprietary approach enables us to provide exceptionally accurate diagnostic data in a timely manner. Being armed with finely detailed and accurate information allows clinicians to gain new insights into the therapeutic needs of the patient and to achieve better outcomes.

Relevant Diagnostics Empowering Actionable Therapy®